✦ LIBER ✦

Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer

✍ Scribed by Annemieke H. Ackerstaff; Coen R. N. Rasch; Alfons J. M. Balm; Jan Paul de Boer; Ruud Wiggenraad; Derek H. F. Rietveld; R. Theo Gregor; Robert Kröger; Michael Hauptmann; Andrew Vincent; Frans J. M. Hilgers

Book ID: 112097537
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 138 KB
Volume: 34
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.21851

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alternating chemoradiotherapy versus par

Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck : Results from a phase III randomized trial

✍ Renzo Corvò; Marco Benasso; Giuseppe Sanguineti; Rita Lionetto; Almalina Bacigal 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

## BACKGROUND. The authors previously have found that in patients with locally advanced squamous cell carcinoma of the head and neck (SCC-HN), alternating chemoradiotherapy (ALT) was superior to low-total-dose conventional radiotherapy alone. The purpose of this randomized trial was to compare the

104 The five year results of a randomize

104 The five year results of a randomized trial of sequential versus concomitant cisplatin and fluorouracil and radiation in advanced head and neck cancer

✍ K.L. Griem; A.K. Murthy; J.-M. Vannetzel; M.S. Kies; B.B. Mittal; J.L. Showel; J 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 105 KB

8502 Long term (Five-year) results of Ta

8502 Long term (Five-year) results of Tax324: A Phase III Trial of Sequential Therapy comparing TPF with PF in Patients with locally advanced squamous cell cancer of the head and neck

✍ Lorch, J.; Haddad, R.I.; Fasciano, J.; Goloubova, O.; Cullen, K.; Posner, M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

The added value of the combined evaluati

The added value of the combined evaluation of clinical efficacy, quality of life and cost-effectiveness in a randomized phase III study. Results of an EORTC — NCIC — SAKK neoadjuvant trial in patients with locally advanced breast cancer (LABC)

✍ Therasse, P.; Mauriac, L.; Welnicka, M.; Bruning, P.; Cufer, T.; Lichinitser, R. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Alternating chemoradiotherapy versus par

Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck: results from a phase III randomized trial: R. Corvo, M. Benasso, G. Sanguineti, R. Lionetto, A. Bacigalupo, G. Margarino, E. Pallestrini, M. Merlano, V. Vitale, R. Rosso. Cancer 2001 Dec 1;92(11):2856–67

✍ G Noël; J.J Mazeron 📂 Article 📅 2002 🏛 Elsevier Science 🌐 French ⚖ 31 KB